BioSpace News Archive

BlackThorn Therapeutics was acquired by Neumora Therapeutics in 2020.

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.

Travere Therapeutics is determined to bring life-changing treatments, support, and hope to people with rare disease.

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.

Blade Therapeutics is closed

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience.

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system.

At Adicet, we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting cancer.

Nitto BioPharma Inc. offers unique drug and nucleic acid (siRNA, miRNA, mRNA, etc) delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells.